Lactacystin Increases LDL Receptor Level on HepG2 Cells

By Miura H.   Tomoda H.   Miura K.   Takishima K.   Omura S.  

Biochemical and Biophysical Research Communications, Vol. 227, Iss. 3, 1996-10 ,pp. : 684-687

Elsevier

Access to resources Recommend Favorite

Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells

By Sanchez M.G.   Sanchez A.M.   Ruiz-Llorente L.   Diaz-Laviada I.  

FEBS Letters, Vol. 555, Iss. 3, 2003-12 ,pp. : 561-566

Elsevier

Access to resources Recommend Favorite

Regulation of Growth, PSA/PAP and Androgen Receptor Expression by 1alpha,25-Dihydroxyvitamin D 3 in the Androgen-Dependent LNCaP Cells

By Hsieh T.C.   Ng C.Y.   Mallouh C.   Tazaki H.   Wu J.M.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 1, 1996-06 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Induction of Apoptosis and Altered Nuclear/Cytoplasmic Distribution of the Androgen Receptor and Prostate-Specific Antigen by 1,25-Dihydroxyvitamin D₃in Androgen-Responsive LNCaP Cells

By Hsieh T-c.   Wu J.M.  

Biochemical and Biophysical Research Communications, Vol. 235, Iss. 3, 1997-06 ,pp. : 539-544

Elsevier

Access to resources Recommend Favorite

Human CYP3A4-introduced HepG2 cells: In vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity

By Araki N.   Tsuruoka S.   Wang N.   Hasegawa G.   Yanagihara H.   Ando H.   Omasa T.   Enosawa S.   Nagai H.   Fujimura A.  

Xenobiotica, Vol. 38, Iss. 11, 2008-11 ,pp. : 1355-1364

Informa Healthcare

Access to resources Recommend Favorite